Atlas Trials

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes

Clinical trial NCT02929901 · COMPLETED

Trial details

NCT number
NCT02929901
Sponsor
National Nutrition and Food Technology Institute
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Nonalcoholic Fatty Liver
Start date
2016-12-01
Primary completion
2018-09-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.